Nonalcoholic fatty liver disease: The hepatic metabolic syndrome

Abstract

Abstract Purpose: To examine a case of nonalcoholic fatty liver disease (NAFLD) and review the incidence, pathophysiology, appropriate diagnostic procedures and imaging, clinical considerations, and treatment options. Data sources: Findings from the history, physical examination, and diagnostic testing of a 39‐year‐old man with elevated liver enzymes presenting to the hepatology clinic; a search of evidence‐based literature in the PubMed and CINAHL database with the terms “fatty liver,”“nonalcoholic fatty liver disease,” and “nonalcoholic steatohepatitis.” Conclusions: NAFLD is the deposition of fat in the liver that can progress to nonalcoholic steatohepatitis, resulting in fibrosis and cirrhosis. The exact pathophysiology is unknown, but risk factors can include those criteria associated with metabolic syndrome. NAFLD is a diagnosis of exclusion and can lead to serious health consequences if it is not identified and interventions are not implemented promptly. Treatment options remain limited but currently focus on weight loss, exercise, and diet. Implication for practice: The clinician must include the spectrum of NAFLD in the differential diagnosis for any patient with elevated liver enzymes. The key actions for diagnosing NAFLD are identifying risk factors and ordering appropriate testing for confirmation. These considerations will lead to early diagnosis and implementation of treatment interventions.